Novel coronavirus rapid detection kit（SARS-COV-2 IgG/IgM）

The rapid detection kit for sars-cov-2 antigen is an immunoassay for the qualitative detection of novel coronavirus in human saliva by side flow chromatography. It is suitable for the auxiliary diagnosis of sars-cov-2 virus infection. Covid-19 caused by sars-cov-2 is an acute respiratory infectious disease. People are usually susceptible. At present, patients infected with covid-19 are the main source of infection; Asymptomatic infected persons may also have infectious sources. According to the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are seen in some cases. The rapid detection kit for sars-cov-2 antigen is an immunoassay (oropharyngeal swab, nasopharyngeal swab and pre nasal swab) specimen used for qualitative detection of sars-cov-2 antigen in human swabs by lateral flow chromatography. The rapid detection kit for sars-cov-2 antigen is a side flow chromatography immunoassay. The test box includes: 1) Burgundy conjugated pad containing recombinant antigen (monoclonal mouse anti-sars-cov-2 antibody conjugate) and rabbit IgG gold conjugate coupled with colloidal gold, 2) nitrocellulose membrane strip containing test band (t-band) and control band (C-band). The band was pre coated with monoclonal mouse anti-sars-cov-2 NP antibody for detection of sars-cov-2 NP antigen, and the C band was pre coated with Goat anti rabbit. When a sufficient volume of sample is dispensed into the sample, in the hole of the test box, the sample migrates on the box by capillary action.